X
Search
X

Patient Support Hotline

Call (844) 244-1309

ZERO360 is a free, comprehensive patient support service to help patients and their families navigate insurance and financial obstacles to cover treatment and other critical needs associated with cancer.

X

Subscribe to our E-Newsletter

Stay up-to-date on the latest news about prostate cancer. Join our distribution list to receive periodic email updates and our monthly e-newsletter.

  • Patient Support (844) 244-1309
  • Search
  • e-News Signup Enews Signup
  • Run/Walk
  • Donate

- test

FDA IDENTIFIES NO NEW SAFETY CONCERNS ASSOCIATED WITH PROSTATE CANCER TREATMENT VACCINE SIPULEUCEL-T

Sipuleucel-T was the first therapeutic vaccine approved by the U.S. Food and Drug Administration (FDA) in 2010. It is indicated... Read More

ZYTIGA May Benefit Newly Diagnosed High-Risk Metastatic Prostate Cancer

Janssen announced the submission of a supplemental New Drug Application (sNDA) to the FDA seeking to expand the indication of... Read More

Incidence of Metastatic Prostate Cancer at Diagnosis Rises in US

After years of decline following the introduction of PSA screening, according to a new study there has been a rise in... Read More

5ARIs Found Not Linked To Increased Prostate Cancer Mortality

Lauren P. Wallner, PhD, MPH is an Assistant Professor, Departments of Medicine and Epidemiology at the University of Michigan. She... Read More